Prevalence and risk factors for diabetes mellitus in moderate term survivors of liver transplantation

American Journal of Transplantation

Volumn 6, Issue 8, 2006, Pages 1890-1895

  Saab, S ^a,b   Shpaner, A ^a   Zhao, Y ^a,c   Brito, I ^a   Durazo, F ^a,b   Han, S ^a,b   Farmer, D G ^a,b   Ghobrial, R M ^a,b   Yersiz, H ^a,b   Goldstein, L I ^a,b   Tong, M J ^a   Busuttil, R W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Diabetes mellitus; Liver transplantation

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GENDER; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; UNIVARIATE ANALYSIS;

DIABETES MELLITUS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SURVIVAL RATE;

EID: 33745797963     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01385.x     Document Type: Article

References (42)

1. Hanto DW, Fishbein TM, Pinson CW et al. Liver and intestine transplantation: Summary analysis, 1994-2003. Am J Transplant 2005; 5: 916-933.
2. Stegall MD, Everson G, Schroter G, Bilir B, Karrer F, Kam I. Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. Transplantation 1995; 60: 1057-1060.
3. Reuben A. Long-term management of the liver transplant patient: Diabetes, hyperlipidemia, and obesity. Liver Transpl 2001; 7: S13-S21.
4. Rabkin JM, de La Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. Am J Surg 2001; 181: 475-479.
5. Asfar S, Metrakos P, Fryer J et al. An analysis of late deaths after liver transplantation. Transplantation 1996; 61: 1377-1381.
6. Pruthi J, Medkiff KA, Esrason KT et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7: 811-815.
7. Shields PL, Tang H, Neuberger JM, Gunson NK, McMaster P, Pirenne J. Poor outcome in patients with diabetes mellitus undergoing liver transplantation. Transplantation 1999; 68: 530-535.
8. Baid S, Cosimi AB, Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066-1072.
9. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002; 74: 1007-1012.
10. Stockmann M, Steinmuller T, Nolting S, Neuhaus P. Posttransplant diabetes mellitus after orthotopic liver transplantation. Transplant Proc 2002; 34: 1571-1572.
11. Navasa M, Bustamante J, Marroni C et al. Diabetes mellitus after liver transplantation: Prevalence and predictive factors. J Hepatol 1996; 25: 64-71.
12. Trail KC, McCashland TM, Larsen JL et al. Morbidity in patients with posttransplant diabetes mellitus following orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 276-283.
13. Steinmuller TH, Stockmann M, Bechstein WO, Settmacher U, Jonas S, Neuhaus P. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes 2000; 108: 401-405.
14. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002; 8: 708-713.
15. Wahlstrom J, Cooper G, Gores C, Rosen C, Wiesner R, Krom RAF. Survival after liver transplantation in diabetics. Transplant Proc 1991; 23: 1565-1566.
16. Trail KC, Stratta RJ, Larsen JL et al. Results of liver transplantation in diabetic recipients. Surgery 1993; 114: 650-656.
17. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection. Liver Transpl 2004; 10: 349-355.
18. Marroni CA, Hoppe L, Diehl JL et al. Diabetes mellitus and liver transplantation in adults. Transplant Proc 1999; 31: 3046.
19. Ericzon B, Groth C, Bismuth H et al. Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. Transpl Int 1994; 7 (Suppl 1): S11-S14.
20. Tueche SG. Diabetes mellitus after liver transplant new etiologic clues and cornerstones for understanding. Transplant Proc 2003; 35: 1466-1468.
21. Al Dosary AA, Ramji AS, Elliott TG et al. Post-liver transplantation diabetes mellitus: An association with hepatitis C. Liver Transpl 2002; 8: 356-361.
22. Blanco JJ, Herrero JI, Quiroga J et al. Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse events. Liver Transpl 2001; 7: 226-233.
23. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000; 32: 209-217.
24. Fraser GM, Grammoustianos K, Reddy J, Rolles K, Davidson B, Burroughs AK. Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: A positive therapeutic aim. Liver Transpl Surg 1996; 2: 411-417.
25. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-1139.
26. Mora PF. Post-transplantation diabetes mellitus. Am J Med Sci 2005; 329: 86-94.
27. Tietge UJ, Selberg O, Kreter A et al. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation. Liver Transpl 2004; 10: 1030-1040.
28. American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care 2004; 27: S11-S14.
29. Davidson JA, Wilkinson A. International expert panel on new-onset diabetes after transplantation. New-onset diabetes after transplantation 2003 International Consensus Guidelines: An endocrinologist's view. Diabetes Care 2004; 27: 805-812.
30. Chobanian AV, Bakris GL, Black HR et al. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
31. US Department of Labor Bureau of Labor Statistics. Standard Occupational Classification User Guide. Available at: http://www.bls.gov/soc/socguide.htm. Accessed August 1, 2005.
32. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
33. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int 2004; 24: 1-8.
34. Jindal RM. Post transplant diabetes mellitus - a review. Transplantation 1994; 58: 1289-1298.
35. Marchetti P. New-onset diabetes after liver transplantation: From pathogenesis to management. Liver Transpl 2005; 11: 612-620.
36. Steinmuller T, Stockmann M, Jonas S et al. The impact of liver transplantation on diabetes mellitus. Transplant Proc 2001; 33: 1393.
37. Canzanello VJ, Schwartz L, Taler SJ et al. Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus (FK506). Liver Transpl Surg 1997; 3: 1-9.
38. Fernandez LA, Lehmann R, Luzi L et al. The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999; 68: 1532-1541.
39. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg 2002; 183: 595-599.
40. Varo E, Padin E, Otero E et al. Cardiovascular risk factors in liver allograft recipients: Relationship with immunosuppressive therapy. Transplant Proc 2002; 34: 1553-1554.
41. Levy G, Villamil F, Samuel D et al., LIS2T Study Group. Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with CO monitoring in de novo liver transplantation. Transplantation 2004; 77: 1632-1638.
42. Lohmann T, List C, Lamesch P et al. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus. Exp Clin Endocrinol Diabetes 2000; 108: 347-352.